Showing 2,181 - 2,200 results of 101,053 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 1.27s Refine Results
  1. 2181
  2. 2182

    Exposures to PM<sub>2.5</sub>, PM<sub>10</sub> and Nitrogen dioxide. by Chika Edward Uzoigwe (20460686)

    Published 2024
    “…The vast majority (96%) of hip fracture units were located in zones where mean PM<sub>2.5</sub> levels exceeded that required by the WHO guidance. …”
  3. 2183

    SIRT5 is a proviral factor. by Marius Walter (13775591)

    Published 2022
    “…<b>E</b>. Decrease in cell-associated viral mRNA levels in A549-ACE2 cells infected with SARS-Cov-2 for 3 days at MOI = 0.1, and treated with SIRT5 and SIRT1 inhibitors Sirt5-i and Ex-527, as shown by RT-qPCR. …”
  4. 2184
  5. 2185
  6. 2186
  7. 2187

    Original data. by Yaotian Fan (5917766)

    Published 2025
    Subjects:
  8. 2188
  9. 2189
  10. 2190
  11. 2191
  12. 2192
  13. 2193

    Effects of Cyr61 and Wnt5a on regenerating vasculature and musculature. by Devon C. Snow-Lisy (798898)

    Published 2015
    “…(B) Wnt5aOX demonstrated mean muscle content most comparable to MSC/CD34<sup>+</sup> HSPC grafts [percent red (muscle): (red (muscle) pixels / red (muscle) + blue (collagen) pixels)]. (§ Unseeded, MSC and MSC/CD34<sup>+</sup> HSPC data, shown as solid and dotted lines, previously reported [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0138643#pone.0138643.ref007" target="_blank">7</a>]). …”
  14. 2194
  15. 2195

    Mean SARS-CoV-2 viral load log 10 between groups. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log<sub>10</sub> within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”
  16. 2196

    Mean (± Standard Error) relative distribution (%) of the energy contained in the signal up to 200 Hz as a function of the frequency bands on the X-, Y- and Z-axis of the racket accelerometer (XR, YR and ZR, respectively) and X-axis of the wrist accelerometer (XW), for both decreased (V-) and increased (V+) velocity conditions (left), and for both lightly vibrant (RL) and highly vibrant (RH) rackets (right), with * for p≤0.05, ** for p ≤ 0.01, and *** for p ≤ 0.001. by Isabelle Rogowski (613715)

    Published 2015
    “…<p>Mean (± Standard Error) relative distribution (%) of the energy contained in the signal up to 200 Hz as a function of the frequency bands on the X-, Y- and Z-axis of the racket accelerometer (XR, YR and ZR, respectively) and X-axis of the wrist accelerometer (XW), for both decreased (V-) and increased (V+) velocity conditions (left), and for both lightly vibrant (RL) and highly vibrant (RH) rackets (right), with * for p≤0.05, ** for p ≤ 0.01, and *** for p ≤ 0.001.…”
  17. 2197
  18. 2198
  19. 2199

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    “…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”
  20. 2200